American Heart Journal
Volume 148, Issue 3 , Pages 475-480 , September 2004

Extended follow-up of patients randomly assigned in the angiotensin-converting enzyme inhibition post-revascularization study (APRES)

  • Lars Kjøller-Hansen, MD

      Affiliations

    • Heart Center, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
    • Corresponding Author InformationReprint requests: Dr Lars Kjøller-Hansen, Department of Medicine-Cardiology Section, Roskilde Hospital, Køgevej 7-13, DK-4000 Roskilde, Denmark.
    • ,
  • Rolf Steffensen, MD

      Affiliations

    • Department of Cardiology, Hillerød Hospital, Hillerød, Denmark
    • ,
  • Peer Grande, MD, PhD

      Affiliations

    • Heart Center, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark

Received 17 December 2003 ,Accepted 10 April 2004.

References 

  1. SOLVD Investigators . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection functions. N Engl J Med. 1992;327:685–691
  2. St John Sutton M, Pfeffer MA, Plappert T, et al.  Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction (the protective effects of captopril). Circulation. 1994;89:68–75
  3. Heart Outcomes Prevention Evaluation Study (HOPE) Investigators . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med. 2000;342:145–153
  4. Fox KM. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators (efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)). Lancet. 2003;362:782–788
  5. Kjøller-Hansen L, Steffensen R, Grande P. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES). J Am Coll Cardiol. 2000;35:881–888
  6. MacMahon S, Sharpe N, Gamble G, et al.  Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. J Am Coll Cardiol. 2000;36:438–443
  7. Lonn E. Dose response of ACE inhibitors (implications of the SECURE trial). Curr Control Trials Cardiovasc Med. 2001;2:155–159
  8. Kjøller-Hansen L, Steffensen R, Grande P. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure. J Am Coll Cardiol. 2001;37:1214–1220
  9. Hamer AW, Takayama M, Abraham KA, et al.  End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation. 1994;90:2899–2904
  10. Kjøller-Hansen L, Steffensen R, Grande P. Effect of ramipril on postrevascularization prevalence of angina and quality of life. Int J Cardiol. 2004;95:159–65
  11. Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
  12. Køber L, Torp-Pedersen C, Carlsen J, et al.  An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multicentre studies. Eur Heart J. 1994;15:1616–1620
  13. Yusuf S, Zucker D, Peduzzi P, et al.  Effect of coronary artery bypass graft surgery on survival (overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration). Lancet. 1994;344:563–570
  14. Holmes DR, Detre KM, Williams DO, et al.  Long-term outcome of patients with depressed left ventricular function undergoing percutaneous transluminal coronary angioplasty. Circulation. 1993;87:21–29
  15. Wang TJ, Evans JC, Benjamin EJ, et al.  Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003;108:977–982
  16. Lewis EF, Moye LA, Rouleau JL. Predictors of late development of heart failure in stable survivors of myocardial infarction (the CARE Study). J Am Coll Cardiol. 2003;42:1446–1453
  17. Bolognese L, Neskovic AN, Parodi G, et al.  Left ventricular remodeling after primary coronary angioplasty (patterns of LVD and long-term prognostic implications). Circulation. 2002;106:2351–2357

PII: S0002-8703(04)00192-9

doi: 10.1016/j.ahj.2004.04.004

American Heart Journal
Volume 148, Issue 3 , Pages 475-480 , September 2004

Article Tools

* Image Usage & Resolution